GPCR Therapeutics launches multiple myeloma trial
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has…
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has…
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a marketing authorisation application (MAA)…
Legend Biotech Corporation has announced that China’s National Medical Products Administration (NMPA) has formally accepted…
Step Pharma has announced encouraging pre-clinical data on its first-in-class, highly selective, orally bioavailable CTPS1…
KAHR Medical, a clinical stage biotech company that is developing a treatment for solid tumors…
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in…
A Swedish biotech company says it believes its treatment could be the ‘canary in the…
Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop…
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
Janssen will discontinue a Phase I study testing Danish biotech Genmab's blood cancer blockbuster daratumumab…
Now that we've got the bad news out of the way, we're here to spread…
Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a…